204 related articles for article (PubMed ID: 25581585)
1. Response to 'Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial: a critical appraisal'.
Arits A; Nelemans P; Kelleners-Smeets N
Br J Dermatol; 2015 Jan; 172(1):11-2. PubMed ID: 25581585
[No Abstract] [Full Text] [Related]
2. Commentary on 'Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial'.
Nijsten T
Br J Dermatol; 2015 Jan; 172(1):12. PubMed ID: 25581586
[No Abstract] [Full Text] [Related]
3. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial: a critical appraisal.
Lecluse LL; Spuls PI
Br J Dermatol; 2015 Jan; 172(1):8-10. PubMed ID: 25581584
[TBL] [Abstract][Full Text] [Related]
5. Effect of pigmentation on photodynamic therapy.
Apalla Z; Lallas A; Sotiriou E; Ioannides D
Lancet Oncol; 2013 Aug; 14(9):e339-40. PubMed ID: 23896270
[No Abstract] [Full Text] [Related]
6. Effect of pigmentation on photodynamic therapy - Authors' reply.
Arits A; Kelleners-Smeets NW
Lancet Oncol; 2013 Aug; 14(9):e340. PubMed ID: 23896273
[No Abstract] [Full Text] [Related]
7. Treating basal-cell carcinoma in a real life setting.
Dummer R
Lancet Oncol; 2013 Jun; 14(7):572-3. PubMed ID: 23683749
[No Abstract] [Full Text] [Related]
8. Cost-effectiveness of topical imiquimod and fluorouracil vs. photodynamic therapy for treatment of superficial basal-cell carcinoma.
Arits AH; Spoorenberg E; Mosterd K; Nelemans P; Kelleners-Smeets NW; Essers BA
Br J Dermatol; 2014 Dec; 171(6):1501-7. PubMed ID: 24749843
[TBL] [Abstract][Full Text] [Related]
9. Tumor thickness and adnexal extension of superficial basal cell carcinoma (sBCC) as determinants of treatment failure for methylaminolevulinate (MAL)-photodynamic therapy (PDT), imiquimod, and 5-fluorouracil (FU).
Roozeboom MH; van Kleef L; Arits AH; Mosterd K; Winnepenninckx VJ; van Marion AM; Nelemans PJ; Kelleners-Smeets NW
J Am Acad Dermatol; 2015 Jul; 73(1):93-8. PubMed ID: 25935596
[TBL] [Abstract][Full Text] [Related]
10. Complete remission of nodular basal cell carcinoma after combined treatment with photodynamic therapy and imiquimod 5% cream.
Devirgiliis V; Panasiti V; Curzio M; Gobbi S; Rossi M; Roberti V; Calvieri S
Dermatol Online J; 2008 Feb; 14(2):25. PubMed ID: 18700128
[No Abstract] [Full Text] [Related]
11. Photodynamic therapy vs. topical imiquimod for treatment of superficial basal cell carcinoma: a subgroup analysis within a noninferiority randomized controlled trial.
Roozeboom MH; Nelemans PJ; Mosterd K; Steijlen PM; Arits AH; Kelleners-Smeets NW
Br J Dermatol; 2015 Mar; 172(3):739-45. PubMed ID: 25066012
[TBL] [Abstract][Full Text] [Related]
12. Fractionated 5-aminolevulinic acid photodynamic therapy in the treatment of a giant recurrent superficial basal cell carcinoma.
Sotiriou E; Apalla Z; Ioannides D
Photodermatol Photoimmunol Photomed; 2009 Dec; 25(6):331-2. PubMed ID: 19906170
[No Abstract] [Full Text] [Related]
13. Five-Year Results of a Randomized Controlled Trial Comparing Effectiveness of Photodynamic Therapy, Topical Imiquimod, and Topical 5-Fluorouracil in Patients with Superficial Basal Cell Carcinoma.
Jansen MHE; Mosterd K; Arits AHMM; Roozeboom MH; Sommer A; Essers BAB; van Pelt HPA; Quaedvlieg PJF; Steijlen PM; Nelemans PJ; Kelleners-Smeets NWJ
J Invest Dermatol; 2018 Mar; 138(3):527-533. PubMed ID: 29045820
[TBL] [Abstract][Full Text] [Related]
14. Fibroepithelioma of Pinkus: poor response to topical photodynamic therapy.
Park MY; Kim YC
Eur J Dermatol; 2010; 20(1):133-4. PubMed ID: 19919909
[No Abstract] [Full Text] [Related]
15. 5-Aminolevulinic acid based photodynamic therapy for basal cell carcinoma: a 10-years follow-up study.
Christensen E
Stomatologija; 2013; 15(3):ii. PubMed ID: 24511763
[No Abstract] [Full Text] [Related]
16. Facial extensive recurrent basal cell carcinoma: successful treatment with photodynamic therapy and imiquimod 5% cream.
Requena C; Messeguer F; Llombart B; Serra-Guillén C; Guillén C
Int J Dermatol; 2012 Apr; 51(4):451-4. PubMed ID: 22435437
[TBL] [Abstract][Full Text] [Related]
17. Histologic subtype of treatment failures after noninvasive therapy for superficial basal cell carcinoma: An observational study.
van Delft LCJ; Nelemans PJ; Jansen MHE; Arits AHMM; Roozeboom MH; Hamid MA; Mosterd K; Kelleners-Smeets NWJ
J Am Acad Dermatol; 2019 Apr; 80(4):1022-1028. PubMed ID: 30582993
[TBL] [Abstract][Full Text] [Related]
18. Comparing Topical Treatments for Basal Cell Carcinoma.
Shaw FM; Weinstock MA
J Invest Dermatol; 2018 Mar; 138(3):484-486. PubMed ID: 29395168
[TBL] [Abstract][Full Text] [Related]
19. Nodular basal cell carcinoma: when in doubt, cut it out.
Brownell I
J Drugs Dermatol; 2007 Dec; 6(12):1245-6. PubMed ID: 18189068
[TBL] [Abstract][Full Text] [Related]
20. A comparison in real clinical practice of methyl aminolevulinate photodynamic therapy and surgery for small superficial basal cell carcinoma: 3-year recurrence rates and cosmetic outcomes.
Sebaratnam DF; Venugopal SS; Murrell DF
J Eur Acad Dermatol Venereol; 2011 Jan; 25(1):117-8. PubMed ID: 20456551
[No Abstract] [Full Text] [Related]
[Next] [New Search]
